Ro4917523 1.5 mg    (DrugBank: -)

1 disease
IDDisease name (Link within this page)Number of trials
206Fragile X syndrome1

206. Fragile X syndrome    [ 98 clinical trials,   73 drugs,   (DrugBank: 27 drugs),   46 drug target genes,   57 drug target pathways]
Searched query = "Fragile X syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 98 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT01517698
(ClinicalTrials.gov)
May 201220/1/2012A Study of RO4917523 in Patients With Fragile X SyndromeA Randomized, Double-blind, 12-week, Parallel Group, Placebo-controlled Study of Efficacy and Safety of RO4917523 in Patients With Fragile X Syndrome.Fragile X SyndromeDrug: Placebo;Drug: RO4917523 0.5 mg;Drug: RO4917523 1.5 mgHoffmann-La RocheNULLCompleted14 Years50 YearsBoth185Phase 2United States;Argentina;Canada;Chile;France;Mexico;Peru;Spain;Sweden;United Kingdom